Remove Heart attacks Remove Quality of Life Remove Research
article thumbnail

Clinical trial finds cell therapy improves quality of life in advanced heart failure

Medical Xpress - Cardiology

Stem cell-based therapy improved quality of life for patients with advanced heart failure, Mayo Clinic researchers and international collaborators discovered in a late-stage multinational clinical trial.

article thumbnail

Heart Failure – Does Testosterone Hold the Key?

Dr. Sanjay Gupta

Heart failure is a chronic clinical syndrome characterised by the inability of the heart to pump out enough blood to meet the body’s requirements. Heart failure or cardiac insufficiency has marked negative effects both on quality of life and quantity of life.

article thumbnail

New Drug Fails to Improve Diabetes-Related Heart Failure

DAIC

The research was presented at the American College of Cardiology ’s Annual Scientific Session. Decline in exercise ability is a hallmark of progression to overt heart failure. Secondary endpoints included change in patients’ overall level of physical activity and in their perception of their symptoms and quality of life.

article thumbnail

Revolutionizing Hypertension Treatment: The Promise of Renal Denervation

Wellnest

This condition poses a heightened risk for cardiovascular events, including heart attacks, strokes, and kidney problems. Latest research in Renal Denervation The Paradise by Recor Medical How does Paradise renal denervation work? Dr. Kirtane echoes concerns about reimbursement, anticipating a potential impediment initially.

article thumbnail

Questioning Beta-Blocker Interruption After Heart Attack

CardiacWire

Results from the ABYSS trial surprised many at ESC 2024, finding that patients who continue beta-blocker therapy after heart attacks have better long-term outcomes than patients who stop taking the drugs, and they don’t experience the quality of life downsides that some might expect. hazard ratio.

article thumbnail

Beta Blockers May Not Benefit Many Heart Attack Survivors

DAIC

The findings call into question the routine use of beta blockers for all patients following a heart attack, which have stood as a mainstay of care for decades. Approximately 50% of heart attack survivors do not experience heart failure. Over a median follow-up period of 3.5

article thumbnail

Leveraging AI-Enabled Remote Cardiac Monitoring to Improve Cardiovascular Care

DAIC

When we address heart disease only after a major event has occurred, weve already missed our greatest chance to control costs, and most importantly, save lives. Research indicates that traditional diagnostic methods fall short often missing early warning signs that occur before a patients condition has progressed.